AI Summary
Researchers have developed nanoparticle technology for targeted diagnosis and treatment of atherosclerosis, a condition characterized by plaque buildup in the arteries. This new approach is non-invasive and represents a significant advancement in cardiovascular medicine. Atherosclerosis is a leading cause of cardiovascular diseases such as ischemic heart disease and stroke, making this technology a promising alternative for managing the condition.
A team developed a nanoparticle technology that offers an effective solution to diagnose and treat atherosclerosis, in a non-invasive manner. Atherosclerosis is the build-up of plaque in the arteries which causes their narrowing and is a primary cause of ischemic heart disease (IHD) and ischemic stroke (IS), major contributors to deaths caused by cardiovascular diseases globally. This theranostic approach represents a significant advancement in the field of cardiovascular medicine as it offers a promising alternative to current medical practices for the management of atherosclerosis.